»Ê¼Ò»ªÈË

Portfolio Pathway is the route to Specialist Registration for doctors who have not completed a specialty training programme in the UK or European Economic Area. For specialist, associate specialist and specialty (SAS) doctors, who may not have completed a training programme, applying through Portfol...

Martha’s Rule, now being piloted in England, enables staff, patients and their families to seek an independent medical review if they feel their concerns about a patient’s care are not being adequately addressed. This page explains the Rule and how it will be implemented across the UK, and will be r...

Specialist, Associate Specialist and Specialty (SAS) doctors are a diverse group of doctors with a wide range of skills and experience, and form an essential part of the paediatric workforce. This resource covers the need to know about SAS careers in paediatrics, whether you are a current SAS doctor...

Our guidance explains rota design and rostering best practice for specialty trainees and foundation doctors. It outlines what to expect from a working week, including time for education and training, provides examples of a work plan and explains the rostering process. It also includes details on min...

The Royal College of Obstetricians and Gynaecologists (RCOG), Royal College of Midwives (RCM), Royal College of General Practitioners (RCGP) and Royal College of Paediatrics and Child Health (RCPCH) issue this advice in a joint statement for worried parents and carers and healthcare professionals on...

This page has updated guidance on the medicine, valproate in accordance with regulation changes from the Medicines & Healthcare products Regulatory Agency (MHRA) in January 2024.

The Research & Evidence team is offering support to members with the development of their own systematic reviews.

This guidance is for trainees at Specialty Training 4 (ST4) or ST5(C4) trainees moving to Progress+ Core level who have been signed off for Level 1 Progress or who are appointed at ST4 with Level 1 capabilities assessed during the recruitment process.

Round 3 of the Epilepsy12 audit was delivered between 1 April 2017 and 31 March 2022. This page provides details on the methodology and data submission process for Round 3. This methodology extends to Round 4, Cohort 4.

Following the crisis in the Middle East, RCPCH has put together this page to signpost to key resources.